RVLP

$0.03-$0.01 (-32.05%)prev close

Compare

Change$-1.07

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

P/S (TTM)

0.1

Earnings surprises

Beat consensus in 6 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2023-11-09	$-0.11	$-0.16	-45.5%
2023-08-14	$-0.13	$-0.13	+0.0%
2023-05-11	$-0.12	$-0.12	+0.0%
2023-03-20	$-0.15	$-0.18	-20.0%
2022-11-10	$-0.19	$-0.16	+15.8%
2022-08-11	$-0.24	$-0.19	+20.8%
2022-05-12	$-0.25	$-0.13	+48.0%
2022-03-30	$-0.29	$-0.26	+10.3%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
RVLPRVL Pharmaceuticals plc	$0.03	-32.05%	$3M	—
AFMDAffimed N.V.	$0.18	+0.00%	$3M	—
ARAVAravive, Inc.	$0.04	-13.39%	$3M	—
BCELAtreca, Inc.	$0.09	-1.32%	$4M	—
BPTSBiophytis S.A.	$8.22	-13.47%	$3M

RVL Pharmaceuticals plc

RVL Pharmaceuticals plc operates as a specialized pharmaceutical firm, concentrating on the creation and commercialization of medicinal products. These offerings target patient populations with unmet needs within the fields of ocular health and medical aesthetics across the United States, Argentina, and Hungary. Among its key commercialized products is Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution specifically developed for adults experiencing acquired blepharoptosis, or drooping eyelids. The company, whose corporate headquarters are located in Bridgewater, New Jersey, underwent a name change in January 2022, transitioning from its former identity as Osmotica Pharmaceuticals plc.

www.rvlpharma.com

Employees: 125
IPO / List date: Oct 19, 2018
HQ: US

Held by traders on TradeandTell

No one on the platform currently holds RVLP.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in RVLP as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded RVLP yet.